-
Exegenesis Bio to Present 9-Patient Data from a Phase 1/2 Clinical Trial of EXG001-307, a Novel rAAV Gene Therapy for Spinal Muscular Atrophy (SMA) Type 1: Improved Head Control and Sitting Without External Assistance
25 Apr 2024 16:52 GMT
… Phase 1/2 clinical trial in Spinal Muscular Atrophy ( … to bring this much-needed treatment option to SMA patients … IND clearances from US FDA and China CDE and … therapy in clinical development for neovascular Age Related Macular Degeneration (nAMD) in …
-
Your Good Health: Over-the-counter eye drops safe with AMD meds
25 Apr 2024 14:28 GMT
… Eylea for wet age-related macular degeneration (AMD). I have just … causes blood and proteins to develop under the retina, leading … of harmful interactions.
Your pharmacist also has access to the … effect on other infections than treatments that are designed to …
-
Over-the-counter eye drops safe to use with AMD medication
25 Apr 2024 07:51 GMT
… Eylea for wet age-related macular degeneration (AMD). I have just … causes blood and proteins to develop under the retina, leading … of harmful interactions.
Your pharmacist also has access to the … effect on other infections than treatments that are designed to …
-
Roche cuts drug pipeline in effort to revitalise business
24 Apr 2024 22:06 GMT
… drug pipeline in six months, shedding prospective cancer and neurology treatments … drugs in development, the company has jettisoned 16 drugs … including wet age-related macular degeneration, recorded sales worth … for pharma”, he added.
Western pharma groups are …
-
SalioGen Therapeutics Selects SGT-1001 as Development Candidate for Stargardt Disease
24 Apr 2024 12:35 GMT
… 1001 as a development candidate for Stargardt disease treatment, a rare inherited … -derived bioengineered enzyme. The treatment utilizes a proprietary lipid nanoparticle … A2E levels, a factor in macular degeneration. Optical Coherence Tomography (OCT) …
-
AstraZeneca’s Voydeya granted EC approval to treat rare blood disease PNH
24 Apr 2024 12:13 GMT
… ) or Soliris (eculizumab), to treat PNH patients with residual haemolytic … ALPHA trial, which evaluated the efficacy and safety of the drug … while maintaining standard-of-care treatment with Soliris or Ultomiris.
“ … form of age-related macular degeneration.
-
Ocugen Completes Dosing in Key Trial for Geographic Atrophy Treatment
24 Apr 2024 06:41 GMT
… trial of OCU410, a novel gene therapy designed to treat … quot;Currently we have two FDA approved, anticomplement therapies for … limited benefit of current treatments that require multiple intravitreal … form of age-related macular degeneration (AMD), a leading …
-
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024
23 Apr 2024 10:13 GMT
… company developing next generation therapeutics to treat medical … advancement in treating age-related macular degeneration (AMD) and … in age-related macular degeneration: Novel drugs, delivery systems, … opens up broader treatment opportunities for multiple …
-
Q&A: Prompt Diagnosis of Age-Related Macular Degeneration
19 Apr 2024 20:12 GMT
Photo Credit: Prostock-Studio
With a projected increase in cases of age-related macular degeneration, prompt diagnosis and treatment are needed to mitigate vision loss and societal burdens.
“Age-related macular degeneration (AMD) affects approximately 20 …
-
Belite Bio Announces $25 Million Registered Direct Offering
25 Apr 2024 23:15 GMT
… Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel … is a clinical-stage biopharmaceutical drug development company focused on advancing … as (i) atrophic age-related macular degeneration (AMD), commonly known as …